Evidence map›Paper›PMID 41608202›Full record

ArticleJournal of the Endocrine Society2026

Interpretable Machine Learning Model for Survival Prediction in Pediatric Adrenocortical Tumors.

Antje Redlich, Elisabeth Pfaehler, Marina Kunstreich, Maximilian Schmutz, Christoph Slavetinsky, Eva Jüttner, Paul-Martin Holterhus, Gert Warncke, Christian Vokuhl, Jörg Fuchs and 2 more

Abstract read
In one paragraph

Article in Journal of the Endocrine Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Antje RedlichDepartment of Pediatrics, Pediatric Hematology/Oncology, Otto-von-Guericke-University, Magdeburg D-39120, Germany.ORCID https://orcid.org/0000-0002-1732-1869
Elisabeth PfaehlerInstitute for Neuroscience and Medicine 4, INM-4, Forschungszentrum Jülich GmbH, Jülich D-52428, Germany.ORCID https://orcid.org/0000-0002-6160-3011
Marina KunstreichDepartment of Pediatrics, Pediatric Hematology/Oncology, Otto-von-Guericke-University, Magdeburg D-39120, Germany.ORCID https://orcid.org/0000-0002-2672-4045
Maximilian SchmutzHematology and Oncology, Faculty of Medicine, University of Augsburg, Augsburg D-86156, Germany.
Christoph SlavetinskyDepartment of Pediatric Surgery and Pediatric Urology, University Children's Hospital, Eberhard-Karls University, Tuebingen D-72076, Germany.ORCID https://orcid.org/0000-0001-5576-5906
Eva JüttnerDepartment of Pathology, University Hospital Schleswig-Holstein, Kiel D-24105, Germany.
Paul-Martin HolterhusDepartment of Pediatrics, Pediatric Endocrinology and Diabetes, University Hospital of Schleswig Holstein (UKSH), Kiel D-24105, Germany.ORCID https://orcid.org/0000-0002-9308-3129
Gert WarnckeDepartment of Pediatrics, Pediatric Intensive Care Unit, Otto-von-Guericke-University, Magdeburg D-39120, Germany.
Christian VokuhlSection of Pediatric Pathology, Department of Pathology, University Hospital Bonn, Bonn D-53127, Germany.
Jörg FuchsDepartment of Pediatric Surgery and Pediatric Urology, University Children's Hospital, Eberhard-Karls University, Tuebingen D-72076, Germany.
Stefan A WudySteroid Research & Mass Spectrometry Unit, Laboratory for Translational Analytics, Pediatric Endocrinology & Diabetology, Center of Child and Adolescent Medicine, Justus Liebig University Giessen, Giessen D-35392, Germany.ORCID https://orcid.org/0000-0002-7163-5957
Michaela KuhlenPediatrics and Adolescent Medicine, Faculty of Medicine, University of Augsburg, Augsburg D-86156, Germany.ORCID https://orcid.org/0000-0003-4577-0503

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Pediatric adrenocortical tumors (pACTs) are rare and clinically heterogeneous. Existing risk stratification systems rely on fixed thresholds and linear assumptions, which may limit their prognostic accuracy-particularly for nonmetastatic, locally advanced cases. We aimed to develop an interpretable machine learning (ML) model for individualized survival prediction using only routine clinical features. Methods: We retrospectively analyzed 97 patients with pACT from the German Pediatric Oncology Hematology-Malignant Endocrine Tumors Registry (1997-2024). An Extreme Gradient Boosting Cox proportional hazards model was trained using 4 features-tumor volume, distant metastases, pathologic T stage, and resection status-identified via systematic feature evaluation across 11 737 model combinations. Performance was assessed using a stratified 80/20 train-test split, 500 bootstrap iterations, and Harrell's concordance index (C-index). SHapley Additive exPlanations (SHAP) were used for interpretability. Results: The model achieved strong prognostic performance (test-set C-index: 0.925; bootstrap mean: 0.891, 95% confidence interval: 0.817-0.946). SHAP analysis confirmed the dominant influence of metastatic status, followed by tumor volume, T stage, and resection status. The model uncovered nonlinear and additive effects, including a SHAP- and bootstrap-guided tumor volume cut-off (190 mL, 95% confidence interval 127-910 mL) that only slightly differed from conventional thresholds. Stratification remained robust in subgroups, including nonmetastatic patients with advanced local disease. Conclusion: This interpretable ML model enables individualized survival prediction in pACT using only routine clinical data. It offers a clinically accessible and clinically meaningful complement to existing scoring systems, particularly in patients with ambiguous risk profiles who may benefit from more personalized management.

Indexed as

adrenocortical tumorschildren and adolescentsinterpretable machine learning modelsurvival prediction

Identifiers

PMID41608202
PMCPMC12838521

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.